Prospective Meta-analysis of Weight Loss Regained and Success Rate of Argon Plasma Coagulation to Suture and Surgery Procedures Post-bariatric Surgery: Status of the Art of Endoscopic Treatment.

IF 1.4 Q4 PHARMACOLOGY & PHARMACY

Reviews on recent clinical trials Pub Date : 2023-01-01 DOI:10.2174/1574887118666230822110724

Idiberto José Zotarelli-Filho, Luiz Gustavo de Quadros, Manoel Galvão Neto, Samadhi W Rajapaksa, Janaki Vidanapathirana, Durval Ribas Filho, Carlos Alberto Nogueira-de-Almeida

{"title":"Prospective Meta-analysis of Weight Loss Regained and Success Rate of Argon Plasma Coagulation to Suture and Surgery Procedures Post-bariatric Surgery: Status of the Art of Endoscopic Treatment.","authors":"Idiberto José Zotarelli-Filho, Luiz Gustavo de Quadros, Manoel Galvão Neto, Samadhi W Rajapaksa, Janaki Vidanapathirana, Durval Ribas Filho, Carlos Alberto Nogueira-de-Almeida","doi":"10.2174/1574887118666230822110724","DOIUrl":null,"url":null,"abstract":"Background: This study performed a meta-analysis to compare the safety and efficacy of argon plasma coagulation (APC) concerning suture (SUT) and surgery (SUR).Methods: The One-Way tests were applied, with p <0.05 significant. The value of R2 was analyzed (heterogeneity), and the risk of bias of articles was evaluated.Results: A total of 34 studies were found, eight about APC, twenty about SUT, and six about SUR. For the percentage of Weight Loss Regained (%WLR), the means for APC, SUT, and SUR were 19.39 ± 10.94, 26.06 ± 16.71, and 17.05 ± 9.85, and for success rate (%SR), the means were 89.75 ± 16.75, 86.80 ± 11.44, and 76.00 ± 21.57, respectively with p >0.05, with R2 ≥ 50%.Conclusion: The APC proved to be efficient and safe like the other techniques.","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":" ","pages":"239-250"},"PeriodicalIF":1.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574887118666230822110724","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This study performed a meta-analysis to compare the safety and efficacy of argon plasma coagulation (APC) concerning suture (SUT) and surgery (SUR).

Methods: The One-Way tests were applied, with p <0.05 significant. The value of R2 was analyzed (heterogeneity), and the risk of bias of articles was evaluated.

Results: A total of 34 studies were found, eight about APC, twenty about SUT, and six about SUR. For the percentage of Weight Loss Regained (%WLR), the means for APC, SUT, and SUR were 19.39 ± 10.94, 26.06 ± 16.71, and 17.05 ± 9.85, and for success rate (%SR), the means were 89.75 ± 16.75, 86.80 ± 11.44, and 76.00 ± 21.57, respectively with p >0.05, with R² ≥ 50%.

Conclusion: The APC proved to be efficient and safe like the other techniques.

查看原文本刊更多论文

氩等离子体凝固术对减肥手术后缝合和手术程序的体重恢复和成功率的前瞻性 Meta 分析：内窥镜治疗艺术的现状。

背景：本研究通过荟萃分析比较了氩等离子体凝固术（APC）对缝合（SUT）和手术（SUR）的安全性和有效性：本研究进行了一项荟萃分析，以比较氩等离子体凝固（APC）对缝合（SUT）和手术（SUR）的安全性和有效性：方法：采用单向检验，P 结果：共找到 34 项研究，其中 8 项关于 APC，20 项关于 SUT，6 项关于 SUR。在体重减轻恢复百分比（%WLR）方面，APC、SUT 和 SUR 的平均值分别为 19.39 ± 10.94、26.06 ± 16.71 和 17.05 ± 9.85，在成功率（%SR）方面，平均值分别为 89.75 ± 16.75、86.80 ± 11.44 和 76.00 ± 21.57，P>0.05，R2≥50%：事实证明，APC 与其他技术一样高效、安全。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-

CiteScore

3.10

自引率

5.30%

发文量

期刊介绍： Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.